Literature DB >> 18174599

Management of cervical cancer: summary of SIGN guidelines.

R M James1, M E Cruickshank, N Siddiqui.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18174599      PMCID： PMC2174776          DOI： 10.1136/bmj.39399.642894.AD

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Clinical practice guidelines for the psychosocial care of adults with cancer. Welcome support for GPs.

Authors:  Jane Turner; Brian McAvoy; Karen Luxford; Jane Fletcher
Journal:  Aust Fam Physician       Date:  2004 Jan-Feb

2.  Variation in the treatment of cervical cancer patients and the effect of consultant workload on survival: a population-based study.

Authors:  Amy Downing; Jasmina Stefoski Mikeljevic; Bob Haward; David Forman
Journal:  Eur J Cancer       Date:  2006-08-28       Impact factor: 9.162

3.  The role of clinical follow up in early stage cervical cancer in South Wales.

Authors:  K C K Lim; R E J Howells; A S Evans
Journal:  BJOG       Date:  2004-12       Impact factor: 6.531

4.  Posttherapy surveillance of women with cervical cancer: an outcomes analysis.

Authors:  D Bodurka-Bevers; M Morris; P J Eifel; C Levenback; M W Bevers; K R Lucas; J T Wharton
Journal:  Gynecol Oncol       Date:  2000-08       Impact factor: 5.482

5.  Recurrent squamous cell carcinoma of cervix after definitive radiotherapy.

Authors:  Ji-Hong Hong; Chien-Sheng Tsai; Chyong-Huey Lai; Ting-Chang Chang; Chun-Chieh Wang; Hung-Hsueh Chou; Steve P Lee; Swei Hsueh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-09-01       Impact factor: 7.038

6.  Emotional support for cancer patients: what do patients really want?

Authors:  M L Slevin; S E Nichols; S M Downer; P Wilson; T A Lister; S Arnott; J Maher; R L Souhami; J S Tobias; A H Goldstone; M Cody
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640
  6 in total
  5 in total

1.  Macrophage migration inhibitory factor expression in cervical cancer.

Authors:  Mathias Krockenberger; Jörg B Engel; Julia Kolb; Yvonne Dombrowsky; Sebastian F M Häusler; Nico Kohrenhagen; Johannes Dietl; Jörg Wischhusen; Arnd Honig
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-14       Impact factor: 4.553

2.  An Alternative Triage Strategy Based on Preoperative MRI for Avoiding Trimodality Therapy in Stage IB Cervical Cancer.

Authors:  Jung-Yun Lee; Jina Youm; Jae Weon Kim; Kidong Kim; Hak Jae Kim; Jeong Yeon Cho; Min A Kim; Noh Hyun Park; Yong-Sang Song
Journal:  Cancer Res Treat       Date:  2015-03-20       Impact factor: 4.679

3.  Prognostic value of posttreatment 18F-FDG PET/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: an analysis of intensity- and volume-based PET parameters.

Authors:  Giacomo Maria Lima; Antonella Matti; Giulio Vara; Giulia Dondi; Nicoletta Naselli; Eugenia Maria De Crescenzo; Alessio Giuseppe Morganti; Anna Myriam Perrone; Pierandrea De Iaco; Cristina Nanni; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-02       Impact factor: 9.236

Review 4.  Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis.

Authors:  Tynisha S Rafael; Jossie Rotman; Oscar R Brouwer; Henk G van der Poel; Constantijne H Mom; Gemma G Kenter; Tanja D de Gruijl; Ekaterina S Jordanova
Journal:  J Clin Med       Date:  2022-02-19       Impact factor: 4.241

Review 5.  Sexual Dysfunction in Cervical Cancer Survivors: A Scoping Review.

Authors:  Neha Mishra; Nilanchali Singh; Mohini Sachdeva; Prafull Ghatage
Journal:  Womens Health Rep (New Rochelle)       Date:  2021-12-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.